Science
Mechanism of Action
The precise biochemical mechanism by which NICOTINOYL TRIPEPTIDE-48 interacts with skin cells or processes is not extensively detailed in current public scientific literature.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Due to a pronounced absence of specific efficacy data and widespread commercial use, there is no evidence to suggest NICOTINOYL TRIPEPTIDE-48 is commonly utilized in 'dusting' practices within formulations. A defined dusting threshold cannot be established without reported clinical concentrations.
The Formula
Formulation
Stability
Specific formulation characteristics, including optimal pH range, solubility profiles, and stability considerations for NICOTINOYL TRIPEPTIDE-48, are not disclosed in public scientific databases.
Safety
Safety Profile
NICOTINOYL TRIPEPTIDE-48 has not undergone specific safety evaluations by major regulatory bodies such as the Cosmetic Ingredient Review (CIR), SCCS, or FDA. While some broader CIR reviews exist for related tripeptides (e.g., NICOTINOYL TRIPEPTIDE-1), a dedicated safety profile for NICOTINOYL TRIPEPTIDE-48 is currently unavailable, thus its individual sensitization potential and suitability for use during pregnancy remain unassessed.
Your Skin
Skin Compatibility
Our Assessment
Verdict
With a critical lack of publicly available research regarding its mechanism, efficacy, safety, and formulation properties, NICOTINOYL TRIPEPTIDE-48 currently possesses insufficient data for a comprehensive scientific assessment in skincare.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources